OFFICIALS LEGISLATION INTEREST GROUPS PUBLIC STATEMENTS COMMITTEES VETOES

Letter to Robert Califf, Commissioner of the Food and Drug Administration - Access to Safe ALS Therapies

Letter

Date: July 15, 2022
Location: Washington, DC
Issues: Health and Health Care

Only available in PDF format; please see source to view document.


Source
arrow_upward